Screening human genes for small alterations performing an enzymatic cleavage mismatched analysis (ECMA) protocol

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Many human diseases stem from subtle genetic alterations requiring complex detection methods.
• Accurate identification of these mutations is crucial for diagnosis and treatment.

Purpose of the Study:

• To evaluate the efficacy of a novel enzymatic protocol for detecting gene mutations.
• To assess the protocol's applicability across diverse monogenic disorders.

Main Methods:

• Utilized a celery-derived, mismatch-specific DNA endonuclease (CEL family) to cleave mismatched DNA sequences.
• Standardized the protocol on known mutations in patients with cystic fibrosis, Fabry's disease, steroid 21-hydroxylase deficiency, and Duchenne/Becker muscular dystrophy.
• Visualized mutation detection using agarose or nusieve/agarose gel electrophoresis.

Main Results:

• The enzymatic protocol demonstrated high efficacy in detecting known mutations across multiple genetic disorders.
• The method proved rapid, simple, safe, and reliable, requiring no specialized equipment or labeling.
• Successfully identified three causative mutations in Duchenne/Becker muscular dystrophy patients.

Conclusions:

• The enzymatic protocol offers a universal and effective approach for point mutation identification in monogenic diseases.
• This assay is feasible for conventional molecular laboratories, even for challenging mutation detection cases.
• The method provides a valuable tool for genetic diagnostics, simplifying the detection of disease-causing alterations.